1. Signaling Pathways
  2. Others
  3. Others

Others

 
Cat. No. Product Name Effect Purity Chemical Structure
  • HY-115960
    Anticancer agent 35
    Anticancer agent 35 (compound 10), a sulfonylurea derivative, is a potent anticancer agent. Anticancer agent 35 inhibits A549, A431, PACA2 cell growth with IC50s of 18.1 µg/mL, 4.0 µg/mL, 18.9 µg/mL, respectively.
    Anticancer agent 35
  • HY-178700
    ALV-05-151-02
    ALV-05-151-02 is a BLC6/BLC6B degrader. ALV-05-151-02 depletes endogenous BCL6 levels in SuDHL4 cells (high BCL6 expression) and BCL6B levels in KYO1 cells (high BCL6B expression). ALV-05-151-02 can be used for the study of hematological malignancies.
    ALV-05-151-02
  • HY-131094
    H-Gly-D-Tyr-OH
    H-Gly-D-Tyr-OH is used for the the solid-phase peptide synthesis.
    H-Gly-D-Tyr-OH
  • HY-N19787
    Corylidin
    Corylidin is a coumarin that can be isolated from Erucaria microcarpa Boiss..
    Corylidin
  • HY-138058
    AF-CX 921
    AF-CX 921 is a strong antiepileptic drug.
    AF-CX 921
  • HY-N10388
    Copteroside G
    Copteroside G is a bisdesmosidic glycoside isolated from the epigeal part of the Climacoptera transoxana.
    Copteroside G
  • HY-153888
    M351-110
    M351-110 is a T-cell activating V-domain immunoglobulin inhibitory factor agonist for cancer research.
    M351-110
  • HY-N19820
    (2E)-N-Isobutylundec-2-ene-8,10-diynamide
    (2E)-N-Isobutylundec-2-ene-8,10-diynamide is an echinacea alkamide that can be used for life science research applications.
    (2E)-N-Isobutylundec-2-ene-8,10-diynamide
  • HY-141814
    TSWV-IN-1
    Inhibitor
    TSWV-IN-1 is a potential anti-TSWV agent that targets TSWV N.
    TSWV-IN-1
  • HY-15866
    FR901465
    FR901465 is a potent anti-cancer and anti-tumor agent. FR901465 can be used for cancer research.
    FR901465
  • HY-N1827
    3-epi-Maslinic acid
    3-epi-Maslinic acid is an acidic pentacyclic triterpene isolated from Hexane and dichloromethane extracts of Platostoma africanum P. Beauv.
    3-epi-Maslinic acid
  • HY-111025
    Ectylurea
    Ectylurea, a N-acylurea, can be used in studies of tension and anxiety symptoms, has no effect on the autonomic nervous system, and has no convulsive, analgesic or antispasmodic activity in animals.
    Ectylurea
  • HY-132967
    Anti-TSWV agent 1
    Inhibitor
    Anti-TSWV agent 1 exhibits excellent inactivation activity against tomato spotted wilt virus (TSWV), with an EC50 value of 144 μg/mL.
    Anti-TSWV agent 1
  • HY-148217
    DB02307
    DB02307 is a dipeptide that contains a sequence of two alpha-amino acids joined by a peptide bond.
    DB02307
  • HY-N19769
    Phenylmethyl O-β-D-glucopyranosyl-(1→3)-O-[β-D-xylopyranosyl-(1→2)]-β-D-glucopyranoside
    Phenylmethyl O-β-D-glucopyranosyl-(1→3)-O-β-D-glucopyranoside (Compound 10) is a triglycoside compound. Phenylmethyl O-β-D-glucopyranosyl-(1→3)-O-β-D-glucopyranoside is isolated from the whole plant of sesame (Sesamum indicum).
    Phenylmethyl O-β-D-glucopyranosyl-(1→3)-O-[β-D-xylopyranosyl-(1→2)]-β-D-glucopyranoside
  • HY-106537
    W 3699
    W 3699 (Probilin; Secrebil; Piprozolin) is a choleretic agent that can be used in the study of biliary diseases.
    W 3699
  • HY-W016584
    4,5-Dichlorocatechol
    Inhibitor
    4,5-Dichlorocatechol is a substrate of the broad-spectrum chlorocatechol 1,2-dioxygenase of pseudomonas chlororaphis RW71. The Ki values for 4,5-dichlorocatechol is 30 nM for the dioxygenase of the Chlorobenzoate-degrading strain Pseudomonas putida AC27 and 4 nM for the dioxygenase of Acidovorax sp. strain PS14.
    4,5-Dichlorocatechol
  • HY-147367
    AM-1488
    Modulator
    AM-1488 is a potent, orally active glycine receptor (GlyR) potentiator (hGlyRα3 EC50=0.45 μM).
    AM-1488
  • HY-147968
    Anticancer agent 74
    Anticancer agent 74 is a moderate anticancer agent. Anticancer agent 74 has lower selectivity and cytotoxicity than doxorubicin to normal cell.
    Anticancer agent 74
  • HY-129706
    LY127210 free base
    LY127210 free base is an orally active peripheral arterial vasodilating antihypertensive agent. LY127210 free base interferes with the baroreflex mechanism, exerts direct myocardial bradycardic activity, has no α or β receptor blocking properties, and acts via all conventional administration routes. LY127210 free base reduces vascular resistance, cardiac output, heart rate, left ventricular end-diastolic pressure, regional vascular resistance, as well as blood flow in the skin and cerebral cortex. LY127210 free base can be used in research related to hypertension.
    LY127210 free base
Cat. No. Product Name / Synonyms Application Reactivity